PT - JOURNAL ARTICLE AU - Helle Marie Christensen AU - Ingrid Titlestad AU - Lotte Huniche TI - Exploration and development of practice with non invasive ventilation (NIV) to patients with chronic obstructive pulmonary disease (COPD) in exacerbation based on the patients, their relatives and healthcare professionals perspectives on treatment DP - 2012 Sep 01 TA - European Respiratory Journal PG - P1210 VI - 40 IP - Suppl 56 4099 - http://erj.ersjournals.com/content/40/Suppl_56/P1210.short 4100 - http://erj.ersjournals.com/content/40/Suppl_56/P1210.full SO - Eur Respir J2012 Sep 01; 40 AB - Background: Assessment of life expectancy and end stage COPD is difficult and often discussed in the clinical setting with regards to the ordination “Not-to-intubate” and “Continuation of respiratory assistance/NIV” as life sustaining treatment. There is little knowledge of how the patients experience NIV, and health care professionals express a need for developing new clinical strategies which draws on patient's perspectives.Aim: To provide insight into how patients with COPD experience treatment with NIV. To develop new clinical strategies for treatment with NIV based on patients, relatives, and health care professionals perspectives.Method: The project is based on critical psychological practice research. A group of co-researchers convenes 10 times over the course of 12 months including the principal researcher and interdisciplinary clinicians from the Department of Respiratory Medicine. The group describes and analyzes practice of NIV treatment in the department. Clinicians contribute with experience based issues, and the researcher contributes with issues based on a combination of fieldwork and semi-structured interviews with patients and their relatives.Results: At present 11 patients who have been hospitalized and treated with NIV in 2011 and 3 of their relatives have been interviewed. Patient interviews revealed that all 11 patients expected and wanted to be treated with NIV if necessary in the future even though 2 patients described fear during treatment and 10 experienced more or less discomfort with the treatment.